Uncategorized
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care and dermatological conditions today announced financial results for fiscal year 2021 and the fourth quarter ended March 31, 2021. “For the past 18 months we have been restructuring the Company to cut losses while positioning it for growth,” sa